Results 51 to 60 of about 57,490 (237)

New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure [PDF]

open access: yesKidney International, 2003
Immunometric assays for parathyroid hormone (PTH) are used extensively to assess bone and mineral metabolism in patients with end-stage renal disease (ESRD) who are treated with dialysis. Results generally correspond to bone histology as documented by bone biopsy, and they are useful in monitoring disease progression.
openaire   +2 more sources

Investigations into the influence of Parathyroid hormone on gene expression in the Colorectal Epithelium [PDF]

open access: yes, 2012
There is good evidence that high dietary calcium intake reduces the incidence of colorectal cancer. The mechanism by which calcium acts is unknown. It was hypothesised that parathyroid hormone (PTH) acts on colorectal epithelium and that calcium acts by ...
Walker, Michael
core  

Intraoperative Fall in Plasma Levels of Intact Parathyroid Hormone in Patients Undergoing Parathyroid Adenomectomy

open access: yesThe International Journal of Biological Markers, 1995
Intraoperative measurement of intact parathyroid hormone (PTH) can be used to evaluate the success of parathyroid surgery in primary hyperparathyroidism associated with parathyroid adenoma.
M. Tommasi   +6 more
doaj   +1 more source

Giant cystic parathyroid adenoma: two case reports and a literature review

open access: yesJournal of International Medical Research, 2022
An uncommon cause of primary hyperparathyroidism is a cystic parathyroid adenoma. This paper describes two patients with hypercalcemia and right knee disease.
Junwei Weng, Weibin Zhou, Yunfei Feng
doaj   +1 more source

Understanding and Addressing Delays in Endocrine Surgery: Insights From a Mixed‐Methods Study and a Pilot Educational Intervention

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Delays in endocrine surgical care contribute to adverse events, patient dissatisfaction, and mortality. Communication is an overlooked contributor. This study identified multi‐level drivers of delay and piloted a provider‐focused intervention. Methods We conducted an IRB‐approved mixed‐methods study.
Stella Kim   +5 more
wiley   +1 more source

Parathyroid hormone receptors in GtoPdb v.2025.3 [PDF]

open access: yes
The parathyroid hormone receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Parathyroid Hormone Receptors [50]) are class B G protein-coupled receptors.
Vilardaga, Jean-Pierre   +11 more
core   +2 more sources

N‑Terminal Phosphorylation of Parathyroid Hormone (PTH) Abolishes Its Receptor Activity [PDF]

open access: yes, 2016
The parathyroid hormone (PTH) is an 84-residue peptide, which regulates the blood Ca2+ level via GPCR binding and subsequent activation of intracellular signaling cascades. PTH is posttranslationally phosphorylated in the parathyroid glands; however, the
Mathias Henze (1716580)   +6 more
core   +1 more source

An unusual case of malignancy-related hypercalcemia

open access: yesInternational Journal of General Medicine, 2013
Mary-Anne Doyle, Janine C Malcolm Division of Endocrinology, University of Ottawa, Ottawa, ON, Canada Objective: To report the case of a 28-year-old woman who presented with hypercalcemia (total calcium =4.11 mmol/L), elevated parathyroid hormone (PTH ...
Doyle MA, Malcolm JC
doaj  

Induced Pluripotent Stem Cell‐Derived Parathyroid Organoids Resemble Parathyroid Morphology and Function

open access: yesAdvanced Science
The primary role of the parathyroid glands is to maintain calcium homeostasis through the secretion of parathyroid hormone (PTH). The limited proliferative capacity and differentiation of parathyroid cells hinder the generation of cell therapy options ...
Selinay Şenkal‐Turhan   +8 more
doaj   +1 more source

Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology — update 2026

open access: yesEndokrynologia Polska
Hypoparathyroidism (HypoPT) remains the last “classic” endocrine deficiency hormone disorder not routinely treated with hormone replacement. In November 2023, European Medicines Agency (EMA), and in August 2024, Food and Drug Administration (FDA ...
Waldemar Misiorowski   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy